New developments in breast cancer research

Noticed some changes? Introducing the new Nature Research brand Trouble viewing this email? Click here to view online EDITOR-IN-CHIEF Larry Norton, MD (Memorial Sloan Kettering Cancer Center, New York, USA) FOUNDING EDITOR Clifford A. Hudis, MD npj Breast Cancer is an online-only, open access, multidisciplinary journal dedicated to publishing high-quality original research articles, reviews, editorials, commentaries, and hypothesis generating observations on all areas of breast cancer research. npj Breast Cancer is published in partnership with the Breast Cancer Research Foundation, and is part of the Nature Partner Journals series. Visit the website to explore all content now available and sign up to receive free article e-alerts, and to explore the benefits of submitting your next manuscript. Research highlights include: Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy Carly Bess Williams, Elizabeth S Yeh & Adam C Soloff DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas Melissa A Troester et al. Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study Valentina I Petkov et al. Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630 Kathy S Albain et al. Submit your next manuscript, and benefit from: Reputation: underpinned by the strength of the Nature Research brand, the journal is published in partnership with the Breast Cancer Research Foundation Comprehensive and rigorous peer review: manuscripts are evaluated by experienced editors and reviewers who are authorities in the field Ease of submission: manuscripts submitted to npj Breast Cancer do not need to adhere to our formatting requirements at the point of initial submission; formatting requirements only apply at the time of acceptance High visibility and wide dissemination to a global audience Compliance with international open access funder mandates Article level metrics, showcasing your personal research impact in academia and beyond Editorial summaries, written to increase the impact and accessibility of your work to the broader community of people living with breast cancer Visit our website to learn more about your open access funding options. Submit a Manuscript Editorial Board Free e-alerts Published in partnership with Part of the Nature Partner Journals series nature.com/npjbcancer As a registered user of Nature Publishing Group's Web sites, our database indicates that you have opted-in to receive product information and special offers. If you no longer wish to receive these e-mails or to discontinue all e-mail services from Nature Publishing Group please update your online account. Modify My Account (Log in to be recognised as a Nature.com registrant). For further information on technical assistance | print subscriptions | other enquiries. Nature Publishing Group | Principal offices: London | New York and Tokyo, and offices in cities worldwide including Basingstoke | Barcelona | Boston | Buenos Aires | Cairo | Delhi | Heidelberg | Madrid | Melbourne | Mexico City | Mumbai | Munich | Paris | San Francisco | Sao Paulo | Seoul | Shanghai and Washington DC. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | US © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All rights reserved.